Sutimlimab, an investigational C1s inhibitor, effectively prevents exacerbation of hemolytic anemia in a patient with cold agglutinin disease undergoing major surgery

Am J Hematol. 2022 Feb 1;97(2):E51-E54. doi: 10.1002/ajh.26409. Epub 2021 Dec 11.

¹ Department of Medicine, Haukeland University Hospital, Bergen, Norway.
² Department of Haematology, Oslo University Hospital and K.G. Jebsen Centre for B-cell malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
³ Department of Anesthesia and Intensive Care, Haukeland University Hospital, Bergen, Norway.
⁴ Section of Cardiothoracic Surgery, Department of Heart Disease, Haukeland University Hospital, Bergen, Norway.
⁵ Sanofi, Cambridge, Massachusetts, USA.
⁶ Sanofi, Warsaw, Poland.
⁷ Department of Research and Innovation, Haugesund Hospital, Haugesund, Norway.

No abstract available

Publication types